An observational study in Hyperplasia and Dysplasia, sponsored by Hôpital Edouard Herriot. Active, not recruiting at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-09-21.
Sponsored by Hôpital Edouard Herriot · Observational
The main purpose is to describe clinical practices nowadays prospectively about patients with a dysplasia diagnosis or another histological lesions.
It will be identified colic situation during the initial colonoscopy after dysplasia diagnosis or atypical lesion.
Also the frequency and the type of monitoring conducted about these patients(surgical and endoscopic treatments).
The main criterion evaluation will be the surgical and endoscopic rates during the time.
The treatments offered such as surgical, endoscopic ones or none of them will be followed.
Finally, the outcome of these patients: stability, lesion disappearance, surgery or development of cancer with frequencies for each of them and relationships with histological abnormal colorectal lesion will be measured.
A replay centralized pathological lesion slides corresponding to the different lesion will be done
891 studies on the registry are indexed under Hyperplasia; 103 are open to participants now.
This study's planned enrollment of 300 is above the median of 157 across 238 observational studies indexed under Hyperplasia.
Browse Hyperplasia studies →Hôpital Edouard Herriot is the lead sponsor of 17 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
In France more than 40000 persons are concerned with a high risk of cancer because of ulcerative colitis for example
Exclusion Criteria:
300 patients
endoscopies results
rates of surgery and endoscopic treatments frequency of development of a cancer or a high grade dysplasia according to a type of abnormal histological colorectal lesion
Time frame: 4 years
This study is active, not recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hôpital Edouard Herriot